Surein Arulananda

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

Erinna F. Lee, Tiffany J. Harris, Sharon Tran et al. · Cell Death and Disease · 2019 · 179 citations · Full text

Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non–Small Cell Lung Cancer

Surein Arulananda, Hongdo Do, Ashan Musafer et al. · Journal of Thoracic Oncology · 2017 · 173 citations · Full text

Tumor Biology, Medicine, Cancer Cell Biology +9

Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Emma L. Mitchell, Peter K. H. Lau, Chloe Khoo et al. · European Journal of Cancer · 2018 · 91 citations

Inflammation, Rheumatology, Anti-tumour Response +15

Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma

Surein Arulananda, Bibhusal Thapa, Marzena Walkiewicz et al. · Journal of Thoracic Oncology · 2018 · 46 citations · Full text

Malignant Pleural Mesothelioma, Pathology, Pleural Disease +3

<p>A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia</p>

Jason D. Lickliter, Hui Gan, Mark Voskoboynik et al. · Drug Design Development and Therapy · 2020 · 36 citations · Full text